Jump to content

The Virus and the Economy


Recommended Posts

Oh, 

''The omicron epidemic is being driven by young, vaccinated people, according to mounting data from countries as diverse as the UK, Denmark and South Africa.''  The Telegraph  @Telegraph

 

''Variants emerge because there is selective pressure on the virus.

The vaccine targets a single spike protein.

THAT's the ideal space where a virus will create resistant strains, just like with antibiotics and superbugs''.

  Robert Hoffmann @itechnologynet

 

image.png.d46f55ce76f3869f50b32d53a4a57c45.png

Edited by Caseynotes
Link to comment

Reminder that we already have a proven antiviral treatment with an 80%+ success rate for covid and always have had one, if only govts would allow Drs to use it.

 

''Attorney Ralph Lorigo has won almost all of his MANY cases suing to get Ivermectin to dying patients. Every time the hospital refuses, delays or appeals.

Now its THEIR turn to pay… instead of the patient.

One hospital will owe 50K if Ivermectin not given by 9pm. Gee, I wonder what they’ll do?''  

Pierre Kory, MD MPA @PierreKory

 

''Shocker: just heard the hospital admins were FREAKING out trying to get an RN to give IVM by 9pm. Nothing like 50K & a PR nightmare facing you vs. just another COVID patient dying from a care standard set by profits & supported by the craven (or ignorant) complicity of most MD’s''  

Pierre Kory, MD MPA @PierreKory

10h

Edited by Caseynotes
Link to comment

image.png

image.png

image.png

As the specter of omicron looms large over the festive season, governments around the world are desperately trying to deploy Covid-19 booster shots in order to bolster people’s protection against the more transmissible variant.

It’s been less than a month since the new, heavily-mutated omicron Covid strain was detected and designated a “variant of concern” by the World Health Organization. Prior to this, studies had shown that the immunity provided by Covid vaccines waned after around six months — meaning that booster shots are essential to increasing protective antibodies to fight potential Covid infection.

 

The emergence of omicron has made booster shots even more important. This is because a number of early studies — which have been published prior to peer review due to the urgency of the situation — have shown that Covid vaccines are less effective against the omicron variant compared to the globally dominant delta strain and other variants.

But the same studies have indicated that three vaccine doses — the two preliminary shots plus a booster dose — significantly increases the level of protection against omicron.

Here’s a summary of the studies released to date, and what they have found: CNBC

Link to comment
48 minutes ago, Caseynotes said:

Oh, 

''The omicron epidemic is being driven by young, vaccinated people, according to mounting data from countries as diverse as the UK, Denmark and South Africa.''  The Telegraph  @Telegraph

 

''Variants emerge because there is selective pressure on the virus.

The vaccine targets a single spike protein.

THAT's the ideal space where a virus will create resistant strains, just like with antibiotics and superbugs''.

  Robert Hoffmann @itechnologynet

 

image.png.d46f55ce76f3869f50b32d53a4a57c45.png

Initial findings from South Africa

Last Tuesday, scientists in South Africa, where omicron was first detected, said their small preliminary study into the omicron variant had found that it significantly reduces the antibody protection generated by Pfizer and BioNTech’s vaccine. However, it found that people who had recovered from the virus and received a booster shot would likely have more protection from severe disease.

The scientists concluded that “previous infection, followed by vaccination – or likely a booster – is probably protective against omicron, and almost certainly against severe disease.”

https://www.cnbc.com/2021/12/14/covid-booster-dose-is-crucial-against-omicron-variant-heres-why.html

Link to comment
4 minutes ago, MongiIG said:

Initial findings from South Africa

Last Tuesday, scientists in South Africa, where omicron was first detected, said their small preliminary study into the omicron variant had found that it significantly reduces the antibody protection generated by Pfizer and BioNTech’s vaccine. However, it found that people who had recovered from the virus and received a booster shot would likely have more protection from severe disease.

The scientists concluded that “previous infection, followed by vaccination – or likely a booster – is probably protective against omicron, and almost certainly against severe disease.”

https://www.cnbc.com/2021/12/14/covid-booster-dose-is-crucial-against-omicron-variant-heres-why.html

very odd isn't it, the announcement was a week ago (7th)  that 'Omicron significantly reduces Covid antibody protection (in) Pfizer vaccine recipients'.

But now, natural immunity AND a booster 🤔 is better, ... no thanks. Will be sticking with the good old natural immunity alone that has served well against covid without fail since Feb 2020.

Reminder that this all seems well planned, since the dawn of time generally Dec is the month for cases and Jan for deaths.

Link to comment

Javid says Omicron doubling every two days
 

Javid says Omicron is more transmissible than Delta. The growth in the UK is mirroring what happened in South Africa.

He says the observed doubling time for Omicron is two days. Although there are just 4,713 confirmed cases, scientists estimate that the real number of people getting infected every day is 42 times higher, at around 200,000.

He says scientists have never seen a Covid variant that can spread so quickly. ☹️

Link to comment
4 minutes ago, Caseynotes said:

Pfizer data still show more people died in the vaxxed group.

MISLEADING:

Pfizer’s study states that fourteen people in the placebo group and 15 people in the vaccinated group died before January 2021. The vast majority of the deaths were unrelated to COVID-19. Only two people in the placebo group died of COVID-19 and one person in the vaccinated group died of COVID-19 pneumonia, according to additional Pfizer data obtained by The Associated Press. The rest of the deaths were due to other factors, including heart disease and heart attacks.

The report states that none of the deaths were related to the vaccine.

A widely shared Twitter post misrepresented the significance of the death numbers to falsely suggest those deaths meant the Pfizer’s vaccine doesn’t reduce a person’s chance of dying from the virus: “The pivotal clinical trial for the @pfizer #Covid vaccine shows it does nothing to reduce the overall risk of death. ZERO. 15 patients who received the vaccine died; 14 who received placebo died,” the tweet reads.

But those death figures, which include everyone in the study who died before January 2021, are irrelevant to the question of how efficient the vaccine is at preventing COVID-19 deaths.

The claim made in the Twitter post “is not supportable by these data,” said Dr. David J. Cennimo, an infectious disease expert at the Rutgers New Jersey Medical School.

The fact that both the vaccinated group and the control group had a similar number of deaths from causes other than COVID-19 is to be expected, Cennimo said.

“To exaggerate the example for learning, the Pfizer vaccine doesn’t protect you from lightning strikes so equal numbers of people in the vaccine and the placebo control group should get hit by lightning,” Cennimo said.

In fact, the tweet’s assertion that the Pfizer study aimed to measure efficacy against death is also wrong, Cennimo said. Rather, the study was designed to look at how effective the vaccine is at protecting against symptomatic illness.

Since death from COVID-19 is a much rarer event than a COVID-19 infection, Cennimo said a much larger study sample is needed to answer that question. Real-world data from hundreds of millions of Pfizer vaccine doses administered in the United States, the United Kingdom and Israel, show that the vaccine is exceedingly effective at protecting against death.

Cennimo said it would be concerning if the study showed a significant increase in deaths from a specific cause in the vaccinated group, as that would signal a possible adverse vaccine effect. Instead, the data showed the vaccinated deaths were distributed among a number of causes between both groups.

Link to comment
23 minutes ago, Provaton said:

MISLEADING:

Pfizer’s study states that fourteen people in the placebo group and 15 people in the vaccinated group died before January 2021. The vast majority of the deaths were unrelated to COVID-19. Only two people in the placebo group died of COVID-19 and one person in the vaccinated group died of COVID-19 pneumonia, according to additional Pfizer data obtained by The Associated Press. The rest of the deaths were due to other factors, including heart disease and heart attacks.

The report states that none of the deaths were related to the vaccine.

A widely shared Twitter post misrepresented the significance of the death numbers to falsely suggest those deaths meant the Pfizer’s vaccine doesn’t reduce a person’s chance of dying from the virus: “The pivotal clinical trial for the @pfizer #Covid vaccine shows it does nothing to reduce the overall risk of death. ZERO. 15 patients who received the vaccine died; 14 who received placebo died,” the tweet reads.

But those death figures, which include everyone in the study who died before January 2021, are irrelevant to the question of how efficient the vaccine is at preventing COVID-19 deaths.

The claim made in the Twitter post “is not supportable by these data,” said Dr. David J. Cennimo, an infectious disease expert at the Rutgers New Jersey Medical School.

The fact that both the vaccinated group and the control group had a similar number of deaths from causes other than COVID-19 is to be expected, Cennimo said.

“To exaggerate the example for learning, the Pfizer vaccine doesn’t protect you from lightning strikes so equal numbers of people in the vaccine and the placebo control group should get hit by lightning,” Cennimo said.

In fact, the tweet’s assertion that the Pfizer study aimed to measure efficacy against death is also wrong, Cennimo said. Rather, the study was designed to look at how effective the vaccine is at protecting against symptomatic illness.

Since death from COVID-19 is a much rarer event than a COVID-19 infection, Cennimo said a much larger study sample is needed to answer that question. Real-world data from hundreds of millions of Pfizer vaccine doses administered in the United States, the United Kingdom and Israel, show that the vaccine is exceedingly effective at protecting against death.

Cennimo said it would be concerning if the study showed a significant increase in deaths from a specific cause in the vaccinated group, as that would signal a possible adverse vaccine effect. Instead, the data showed the vaccinated deaths were distributed among a number of causes between both groups.

 

Totally wrong.

The studies are still ongoing and there have been many more deaths since the initial release.

Reminder the FDA don't want you to see all the data for another 75 YEARS.

A randomised controlled trial matches 2 cohorts to be as similar as possible so that ANY differences are almost certainly down to the one thing that was planned to be different, did they or did they not receive the vaccine?

Hence, if more died in the vaxxed group then it was probably down to the vax, no matter what it was.

The latest available data shows there were 4 x more heart attacks in the vaxxed group.

Reminder too that the list of adverse events associated with these vaccines is very long, not just heart attacks.

It's no wonder the vaccines now have NEGATIVE efficacy.

Edited by Caseynotes
Link to comment

Omicron’s greater transmissibility means hospitals will again have to treat large numbers of patients despite it apparently inducing milder symptoms than the previously dominant Delta strain, said Chris Hopson, the chief executive of NHS Providers. He told the all-party parliamentary group on coronavirus.

All the evidence we have in front of us suggests that there will be a considerable impact [from Omicron] in terms of degree of hospitalisations. And the key point to grasp is irrespective in a sense of the severity of the symptoms, if you have a very large number of people who are infected with Omicron, and we know that this variant is significantly more infectious and more transmissible than Delta, it doesn’t take a particularly large percentage of people to be hospitalised before you get a large raw number of hospitalisations and that I think is the concern.

We [the NHS] were already beyond full stretch before we got to winter. We’re now facing the prospect of significant numbers of hospitalisations probably starting I would think in the next week to two weeks.

That is a concern because the NHS is already “beyond full stretch” even before winter has arrived properly, Hopson added.

 

Link to comment
11 minutes ago, Provaton said:

Omicron’s greater transmissibility means hospitals will again have to treat large numbers of patients despite it apparently inducing milder symptoms than the previously dominant Delta strain, said Chris Hopson, the chief executive of NHS Providers. He told the all-party parliamentary group on coronavirus.

All the evidence we have in front of us suggests that there will be a considerable impact [from Omicron] in terms of degree of hospitalisations. And the key point to grasp is irrespective in a sense of the severity of the symptoms, if you have a very large number of people who are infected with Omicron, and we know that this variant is significantly more infectious and more transmissible than Delta, it doesn’t take a particularly large percentage of people to be hospitalised before you get a large raw number of hospitalisations and that I think is the concern.

We [the NHS] were already beyond full stretch before we got to winter. We’re now facing the prospect of significant numbers of hospitalisations probably starting I would think in the next week to two weeks.

That is a concern because the NHS is already “beyond full stretch” even before winter has arrived properly, Hopson added.

 

 

Totally wrong again. Same old garbage Project Fear over and over again. Transmission rate up, severity rate down is the way of normal viral evolution and has been the case for all the covid variants so far. That must mean a decreased rate of hospitalisations and deaths.

Perhaps vaccine adverse events might be the problem?

As for the NHS, they should stop decreasing the number of ICU beds year by year.

 

wint1.PNG.8f07738ef722d110953b4718b0d8b06d.PNG

Link to comment

 

''As it relates to Omicron, two recent small but interesting preliminary studies show that 80% of the omicron cases were double vaccinated.''

 

''As it relates to the vaccinated and unvaccinated being similar in terms of infection, viral load, and transmission capacity, and thus no underlying evidence to separate them societally, we specifically focus on and present (and based largely on Delta variant data) the body of evidence.''

 

Must We Segregate the Unvaccinated from the Vaccinated? ⋆ Brownstone Institute

 

Link to comment
10 minutes ago, Provaton said:

It just shows how underfunded the NHS has been for years.

It doesn't mean that the system can't be under pressure now.

haha, it burns about a billion a week. Same story every winter with new added scaremongering for the covid farce.

Reminder, covid has the same Infection Fatality Rate (IFR) as the common Flu.

Link to comment
15 minutes ago, Caseynotes said:

haha, it burns about a billion a week. Same story every winter with new added scaremongering for the covid farce.

Reminder, covid has the same Infection Fatality Rate (IFR) as the common Flu.

Haha, yeah it's funny that our health system is underfunded and struggling...

Typical flu IFR: 0.1%
COVID estimates of IFR: 0.5 - 1%

COVID-19 is 5 to 10 times more deadly than the flu.

Link to comment
45 minutes ago, Provaton said:

Haha, yeah it's funny that our health system is underfunded and struggling...

Typical flu IFR: 0.1%
COVID estimates of IFR: 0.5 - 1%

COVID-19 is 5 to 10 times more deadly than the flu.

 

 

You would have known the correct answer if you ever actually read the thread, I must have repeated it half a dozen times.

 

REMINDER:

** Covid IFR is 0.096%, which is the same as for the common flu. **

 

(So covid definitely NOT 5 - 10 times more deadly than the flu)

 

image.png.44dc15120597d81697b853101c1ae7ac.png

Written questions and answers - Written questions, answers and statements - UK Parliament

 

 

Meanwhile health and social care burn around £240 billion a year between them so health is more like 2 billion a week, yeah - struggling 🤪

Link to comment
2 hours ago, Provaton said:

No idea how the MP could have made such a mistake!

No, that is official UK govt data, it's you who has made the mistake, again.

You see if you actually read the thread before jumping in with nonsense MSM made up facts you wouldn't keep embarrassing yourself like this.

Might be worth just stopping and having a think before you post.

Link to comment

And so MPs voted for vaccine passports in spite of them not controlling transmissions anywhere they have been implemented.

The vaccines don't reduce infections or transmissions and the infected vaxxed and non vaxxed have the same viral load so it doesn't decrease severity and so won't decrease hospitalisations or deaths either. That's why the data gives us charts that look like this.

data1.PNG.1eab93982dabfcae8daea147e92a7cc8.PNG

 

And so spending 20 months getting nowhere have also shown us that masks don't work, social distancing doesn't work, perspex screens don't work, the vaccines and passports don't work but it was never about a virus anyway. It was always about control and your submission to it.

 

And so the 2019 EU plan to introduce mandatory vaccine passports trundles on as per schedule.

 

image.thumb.png.04231b81994135457537fe7c8eb0651a.png

 

image.thumb.png.dd7c7228888a4bc44144f3058c4dc1b4.png

 

 

Link to comment

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations.

image.png

By Francesco Guarascio

BRUSSELS (Reuters) - Pfizer (NYSE:PFE) and BioNtech are set to displace AstraZeneca (NASDAQ:AZN) as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of their shot for poorer states.

The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.

AstraZeneca is currently the most distributed vaccine by COVAX, according to data from Gavi, the vaccine alliance that co-manages the programme with the World Health Organization (WHO).

The programme has so far delivered more than 600 million shots to nearly 150 countries, of which more than 220 million are AstraZeneca's and about 160 million Pfizer's.

But in the first quarter of next year Pfizer is set to take over, according to Gavi and WHO figures on doses assigned by the COVAX programme for future supplies.

By the end of March, another 150 million Pfizer doses are to be distributed by COVAX, a WHO document shows.

A spokesperson for Gavi confirmed that Pfizer is far ahead in terms of "allocated" jabs, with about 470 million doses delivered or readied for delivery, against 350 million from AstraZeneca.

Pfizer is the first provider of COVID-19 vaccines to the European Union, the United States and Japan.

It has bilateral agreements for more than 6 billion doses, making it by far the largest supplier of COVID-19 vaccines, according to data from UNICEF, a U.N. agency.

But AstraZeneca has been seen as a crucial supplier to less developed countries, because its shot is cheaper and easier to deliver.

COVAX bet heavily on AstraZeneca at the beginning of the pandemic, but supply problems and export restrictions from top producer India gradually reduced its reliance on the Anglo-Swedish shot.

As the programme faced problems in securing doses directly from vaccine makers amid a global scramble for shots, donations from rich nations became more important, turning Pfizer into the main supplier to COVAX. The United States is donating mostly Pfizer shots to the programme.

Reuters.pngCoronavirusDec 15, 2021 

Link to comment

''Pfizer denying anaphylaxis deaths on day of vaccination are linked to vaccine and hiding numbers still symptomatic in with "recovered" is not a good look.''

Dr Clare Craig @ClareCraigPath

 

''The highly confidential Pfizer documents, which have been synonymous with the extreme lack of transparency revealed by the actions of pivotal governmental agencies, over the past 20 months, leads critics of the official narrative to demand “show us the data,” is finally being revealed–well sort of, the first few hundred redacted pages out of a trove of 451,000.''

 

''Within Pfizer’s self-generated document, a serious red flag surfaces:  1228 people were recorded to have died within three months after taking the vaccine, while no record accounts for the gender of the study participants who died. This data, which has significant safety implications, was known to Pfizer by end of February, yet on April 12, Dr Mace Rothenberg former Pfizer Chief Medical Officer, when talking to the Washington Journal about the development of the Pfizer vaccine said “I can tell you that no corners were cut” and “there have been no deaths that have occurred directly as a result of the vaccine alone.” 

 

FDA’s forced hand drops Pfizer’s Bombshell Safety Document (trialsitenews.com)

Link to comment

Brits told to get their 3rd shot as the Israelis are told to get their 4th 🤔

''Israel to approve the 4th shot shortly. It will be the first country with millions of "unvaccinated" people with 3 shots.''  Dr. Eli David  @DrEliDavid

''Today from Deputy-Director of largest hospital in Israel who is also member of Ministry of Health committee for approving vaccines: "Those who think we won't need to take more boosters are wrong. We will need to take the 4th shot, the 5th shot, the 6th shot, and the 7th shot."  Dr. Eli David  @DrEliDavid

 

Imagine being forced to get a jab every 3 months, the claim being it's to stop you from getting a cold in winter.

 

New York Times, finally: "Nearly two years into the pandemic, it is clear that the coronavirus is not going to disappear anytime soon.”

For those who understand infectious disease epidemiology, this was obvious in March 2020.  Martin Kulldorff @MartinKulldorff

 

Meanwhile in no mandates Sweden.

.

image.thumb.png.58ec37dcd9483437573ed013c2021511.png

 

 

 

Link to comment

5 new dominant strains in 20 months (including Omicron) is not normal for a coronavirus, something is pressuring the evolutionary process (the vaccines).  

Vaccine efficacy dropped of a cliff in September when Delta become 99% of all cases showing that Delta had developed vaccine resistance.  

Now Omicron may be going 1 stage further and exploiting the suppressed natural immune system of the vaccinated.  

Reminder that the possibility of this chain of events was warned about when the vaccine programme was announced.   

Not a proper or convincing study but just might be a glimpse of what's to come.  

 

 ''Denmark - Omicron 2,471 cases identified as of 12 December.  

13.5% in unvaccinated  

2.4% One dose only  

74.6% Two doses only  

9.5% booster doses 

In Denmark 16.1% of the population is unvaccinated so based on this the vaccinated are catching it at a higher rate.''

Jamie Jenkins @statsjamie  17h

image.png.c4f9312eacef77b268479e755714c39b.png

 

 

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

  • image.png

  • Posts

    • Yes Goldenbrown, I think you make a good point about being careful when trading.  In my opinion, only trades which are calculated to have a high probability of being correct should be placed. DAX is a market that can look daunting at first, but after a lot of study and experience with it, I have found it to be easier than the others. If you would like to see the answers to your other points, please see my IG Community Profile. Best regards.
    • Renzo leads the charge in revolutionizing staking protocols through the implementation of EigenLayer. This pioneering approach streamlines user re-staking while addressing concerns regarding operator selection and reward management. Participants stake ETH and earn APR from both native and EigenLayer restaking, receiving ezETH tokens—liquid assets for DeFi. Renzo's vision extends to interoperability across Ethereum and Layer 2 chains like Arbitrum, Linea, Mode, Base, BNB, and OKX, ensuring accessibility across diverse ecosystems.Renzo's standout feature lies in the ezETH token's appreciation over time, driven by promised APR, potentially offering superior returns. Seamlessly integrated into DeFi liquidity pools and lending protocols, ezETH provides diversified earning avenues. Compared to similar projects, Renzo distinguishes itself with its innovative liquid staking and interoperability. Supported by investments from Binance Labs and OKX Ventures, Renzo's listing on exchanges like Bitget further solidifies its significance. With 10% allocated for ETH stakers, Renzo fosters community engagement.Eager to explore how Renzo's liquid staking model stacks up against traditional staking? Let's delve into the details!"    
    • I just cheeked my positions and it is now closed. I am guessing it was a time delay between the moment when the markets closed and the moment when the position closed ( about 30 min difference) when the options was still showing as an opened position and with the next day expiry (25)
×
×
  • Create New...
us